VR Logo

PDS Biotechnology Corporation (PDSB) download report


Healthcare | Biotechnology & Pharma Research

PDS Biotechnology Corporation (PDSB) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies.

IPO Date: 01-Oct-2015

Pres, CEO & Director: Dr. Frank K. Bedu-Addo Ph.D.

CFO, Principal Financial & Accounting Officer: Mr. Matthew C. Hill CPA

Listing: NASDAQ: PDSB

Country: United States

Headquarters: Florham Park, NJ

Website: https://www.pdsbiotech.com

Key Facts

Market cap: $107.54 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-22.34 Mln

Cash: $58.88 Mln

Total Debt: $0.46 Mln

Insider's Holding: 17.20%

Liquidity: Low

52 Week range: $2.91 - 17.85

Shares outstanding: 28,450,900

9 Years Aggregate:

  • CFO: $-189.26 Mln
  • EBITDA: $-221.75 Mln
  • Net Profit: $-225.51 Mln

Stock Performance

Time Period PDS Biotechnology (PDSB) S&P BSE Sensex S&P Small-Cap 600
YTD-54.44-9.18-18.78
1 month-31.41-4.78-8.00
3 months-40.39-9.66-13.65
1 Year-70.600.81-17.19
3 Years-14.9110.336.10
5 Years-55.2311.345.87
10 Years--11.749.84
As on 01-Jul-2022
Year PDS Biotechnology (PDSB) S&P Small-Cap 600 S&P BSE Sensex
2021278.5025.2721.99
2020-19.259.5715.75
2019-58.7220.8614.38
2018-96.51-9.705.87
2017-25.0411.7327.91
20160.0024.741.95